Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines

BACKGROUND & AIMS: It is estimated that 3.26 million children and adolescents worldwide have chronic HCV infection. To date, the global response has focused on the adult population, but direct-acting antiviral (DAA) regimens are now approved for children aged ≥3 years. This global review describ...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JHEP Rep
Главные авторы: Malik, Farihah, Bailey, Heather, Chan, Polin, Collins, Intira Jeannie, Mozalevskis, Antons, Thorne, Claire, Easterbrook, Philippa
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2021
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7898178/
https://ncbi.nlm.nih.gov/pubmed/33665586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100227
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы